Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091541

« Back to Dashboard
NDA 091541 describes LOSARTAN POTASSIUM, which is a drug marketed by Sandoz, Alembic Pharms Ltd, Watson Labs, Macleods Pharms Ltd, Unichem Labs Ltd, Lupin Ltd, Hetero Labs Ltd V, Micro Labs Ltd India, Zydus Pharms Usa Inc, Upsher Smith, Teva, Roxane, Torrent Pharms, Cadista Pharms, Vivimed Labs, Aurobindo Pharma, Apotex Corp, Ipca Labs Ltd, Mylan, Prinston Inc, Apotex, and Teva Pharms, and is included in thirty-four NDAs. It is available from sixty-six suppliers. Additional details are available on the LOSARTAN POTASSIUM profile page.

The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-one drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

Summary for NDA: 091541

Micro Labs Ltd India
losartan potassium
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 091541

Suppliers and Packaging for NDA: 091541

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
losartan potassium
TABLET;ORAL 091541 ANDA Micro Labs Limited 42571-110 42571-110-10 1000 TABLET, FILM COATED in 1 BOTTLE (42571-110-10)
losartan potassium
TABLET;ORAL 091541 ANDA Micro Labs Limited 42571-110 42571-110-30 30 TABLET, FILM COATED in 1 BOTTLE (42571-110-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Sep 24, 2012TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.